Related references
Note: Only part of the references are listed.Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation
Richard F. Schlenk et al.
BLOOD (2014)
Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3/ITD AML
D. L. Stirewalt et al.
BLOOD CANCER JOURNAL (2014)
The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia
C. Allen et al.
LEUKEMIA (2013)
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
Richard F. Schlenk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Clinical implications of FLT3 mutations in pediatric AML
Soheil Meshinchi et al.
BLOOD (2006)
Share Paper
